Dysregulated TGF-β signaling activates ERK1/2 and JNK (Zhang, 2009) leading to an increase in aggressive cancer characteristics, such as growth, invasion, migration, and metastasis (Lee et al., 2007). This evidence concerns the gene TGFB1 and cancer.